Mitchell Coyne - 17 Nov 2022 Form 4 Insider Report for Azenta, Inc. (AZTA)

Role
SVP and GM, Life Sciences Proj
Signature
/s/Jason W. Joseph, as attorney-in-fact for Mitchell Coyne
Issuer symbol
AZTA
Transactions as of
17 Nov 2022
Net transactions value
$0
Form type
4
Filing time
21 Nov 2022, 15:29:03 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AZTA Common Stock Award $0 +1,889 $0.000000 1,889 17 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock units to the Reporting Person under the Company's Long Term Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2023.